Please use this identifier to cite or link to this item: https://repositorio.ufba.br/handle/ri/7189
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCunha, Sérgio Souza da-
dc.contributor.authorCruz Filho, Álvaro Augusto Souza da-
dc.contributor.authorDourado, Maria Inês Costa-
dc.contributor.authorBarreto, Mauricio Lima-
dc.contributor.authorFerreira, Leila Denise Alves-
dc.contributor.authorRodrigues, L. C.-
dc.creatorCunha, Sérgio Souza da-
dc.creatorCruz Filho, Álvaro Augusto Souza da-
dc.creatorDourado, Maria Inês Costa-
dc.creatorBarreto, Mauricio Lima-
dc.creatorFerreira, Leila Denise Alves-
dc.creatorRodrigues, L. C.-
dc.date.accessioned2012-11-13T12:44:45Z-
dc.date.issued2004-
dc.identifier.issn0105-4538-
dc.identifier.urihttp://www.repositorio.ufba.br/ri/handle/ri/7189-
dc.descriptionp. 857-862pt_BR
dc.description.abstractBackground: BCG is a vaccine used against tuberculosis and leprosy and is an immunostimulant that primes TH1 lymphocytes to produce cytokines that antagonize atopy both in animal models and in man. Considering that atopy is the main risk factor for asthma, one can hypothesize that vaccination inducing TH1 responses, such as BCG, can be protective against asthma. Methods: Objective: To estimate the association between neonatal BCG vaccination and prevalence of asthma among adolescents. Study design: Crosssectional study with schoolchildren aged 12–16 years. The presence of a scar compatible with BCG was used as a surrogate of neonatal vaccination. A self administered structured questionnaire was prepared based on that used by the International Study of Asthma and Allergies in Childhood. The prevalence of asthma was categorized according to the report of lifetime wheeze, lifetime asthma, lifetime asthma among those referring allergy and among those referring allergy and sneezing. Results: Neonatal BCG vaccination was not associated with the overall prevalence of reported wheezing or asthma. However, in the subgroup reporting current allergy and sneezing, neonatal BCG was associated with a 37% reduction of prevalence of lifetime asthma. Conclusions: In the population we surveyed, neonatal BCG scar was associated with a reduction in the risk of asthma only in individuals with a past history suggestive of allergic rhinitis.pt_BR
dc.language.isoenpt_BR
dc.sourcehttp://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2004.00517.x/pdfpt_BR
dc.subjectallergypt_BR
dc.subjectasthmapt_BR
dc.subjectBCG vaccinept_BR
dc.subjecthypersensitivitypt_BR
dc.subjectrhinitispt_BR
dc.subjectvaccinespt_BR
dc.titleLower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCGpt_BR
dc.title.alternativeAllergypt_BR
dc.typeArtigo de Periódicopt_BR
dc.identifier.numberv. 59, n. 8pt_BR
dc.embargo.liftdate10000-01-01-
Appears in Collections:Artigo Publicado em Periódico Nacional (ISC)

Files in This Item:
File Description SizeFormat 
j.1398-9995.2004.00517.x.pdf
  Restricted Access
108,52 kBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.